Early Access — free while we kick the tires
EdgarHawk

Robertson John Adam

Executive Chairperson

Director Officer 10% Owner
2 filings analyzed · 1 company · Latest 2026-02-02

Companies

Company Buys Sells Direction
Commercial Bancgroup, Inc. CBK 1 2 Net selling

Activity

February 2026
low
Buy
266 shares
$6,969
Significance 3/10

Robertson John Adam bought 266 CBK shares at $26.20; stock already +11.7% in 30 days, near 52-week high.

Robertson John Adam, Executive Chairperson, purchased 266 shares at $26.20, raising his holdings from 45,534 to 45,800 shares (+0.6% net change). The current price of $26.94 sits at the 52-week high of $26.94, with the stock up 11.7% over 30 days and 10.0% over 90 days. His two prior open-market sales at CBK (both on 2025-10-03) each returned +5.6% in 30 days and +6.0% in 90 days, though neither qualified as well-timed at the 90-day mark. The buy occurs after substantial recent appreciation and near a peak valuation relative to the 52-week range, making this a relatively small incremental position increase.

October 2025
critical
Sell
2,958,674 shares
$68,522,890
Significance 9/10

Executive Chairperson Robertson John Adam sold 2,958,674 shares for $68,522,889.84, reducing holdings by 98.5% at CBK

Robertson John Adam, Executive Chairperson of Commercial Bancgroup, Inc., executed 2 separate sales totaling 2,958,674 shares for $68,522,889.84 at $23.16 per share on 2025-10-03. His holdings collapsed from 3,004,208 shares to 45,534 shares—a -98.5% reduction in pre-transaction holdings. The magnitude and breadth of this divestiture are striking: an insider retains minimal economic interest in the company he chairs, with only 45.5K shares remaining. The transaction occurred 4 trading days before the current price of $24.70, making the execution price $1.54 per share below current levels, though this comparison is limited by the stock's recent listing status.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access